Mesa Knee Guide
Where can you discuss PRP care near Mesa?
Choose an office that will also be manageable for later visits. Most Mesa residents may find the Chandler office practical, while people farther north or northeast may have a shorter drive to Scottsdale. Your starting point matters in a city this wide.
Think about the ride home as well.
On clinic forms, PRP names platelet-rich plasma, the part kept after your blood is drawn and separated in a spinning machine because it contains more clot-forming platelets. The knee may feel sore afterward, so ask whether someone needs to drive you, when the clinic expects you back, and whether later visits use the same office. You'll know what to arrange before the day comes.
Which office is nearer for most of Mesa?
The Chandler office is at 1100 S. Dobson Road, Suite 210, Chandler, AZ 85286. From west Mesa, Dobson Road runs south without a freeway. Central Mesa can use US-60 toward Dobson, while southeast Mesa can use Loop 202 Santan.
Choose the drive that feels easier.
The Scottsdale office may be shorter from Las Sendas, Red Mountain, Falcon Field, and areas north of McDowell Road. Its address is 9220 E. Mountain View Road, Suite 210. Loop 202 Red Mountain and Loop 101 connect northern Mesa with that office. Both locations use (602) 837-PAIN.
What will help the first conversation?
Bring your medicine names and any records from past knee visits. Records from X-rays or other scans count, and an earlier doctor's office can send copies if you don't have them. Note how far you walk before soreness rises. Mention trouble with stairs, sleep, or getting up from a chair.
A short note is enough.
You may also write down questions about the full cost and recovery. Ask which medical provider will see you, meaning the doctor, nurse practitioner, or physician assistant responsible for your care. A companion can listen and help remember the answers. You won't need to hold every detail in mind.
What happens during the first visit?
The visit can begin with questions about the soreness and care you've already tried. The person examining you may check swelling, bending, strength, and walking. An X-ray or scan may be discussed if it could help find the cause. You can ask who arranges it and whether there's another charge.
You aren't required to decide that day.
If PRP comes up, ask how the clinic separates your blood and what recovery involves. You can also ask how much relief is realistic and when it will be checked. Other care may still be useful. You can leave once each choice makes sense in plain words.
Sources
-
The ESSKA-ICRS consensus applied the RAND/UCLA appropriateness method to 216 clinical scenarios for intra-articular PRP in knee OA. Only 84 scenarios (38.9%) were rated appropriate, 9 (4.2%) inappropriate and 123 (56.9%) uncertain. PRP was judged appropriate in patients aged 80 or under with KL grade 0-III osteoarthritis AFTER failed conservative non-injective or injective treatment; it was NOT considered appropriate as a first treatment, nor in KL grade IV (bone-on-bone) osteoarthritis, where 91.7% and 87.5% of scenarios respectively were uncertain.
Kon E, de Girolamo L, Laver L, et al. — Platelet-rich plasma injections for the management of knee osteoarthritis: The ESSKA-ICRS consensus. Recommendations using the RAND/UCLA appropriateness method for different clinical scenarios. Knee Surgery, Sports Traumatology, Arthroscopy, 2024. DOI: 10.1002/ksa.12320.
-
Medicare's national coverage policy covers autologous platelet-rich plasma ONLY for patients with chronic non-healing diabetic, pressure and/or venous wounds, and only within an approved coverage-with-evidence-development clinical study. There is no Medicare national coverage for PRP in osteoarthritis or tendinopathy, which is why these injections are billed to the patient as cash-pay.
Centers for Medicare & Medicaid Services — Autologous Platelet-rich Plasma (Coverage with Evidence Development). CMS.gov, 2024.
-
In the RESTORE trial - the largest placebo-controlled PRP trial in knee osteoarthritis - 288 adults aged 50+ with symptomatic Kellgren-Lawrence grade 2-3 medial knee OA received three weekly intra-articular injections of leukocyte-poor PRP from a commercial system or saline placebo. At 12 months the mean change in knee pain was -2.1 points with PRP versus -1.8 with saline (difference -0.4; 95% CI -0.9 to 0.2; P=.17) against a minimum clinically important difference of 1.8, and the change in medial tibial cartilage volume was -1.4% versus -1.2% (difference -0.2%; 95% CI -1.9% to 1.5%; P=.81). Twenty-nine of 31 prespecified secondary outcomes showed no significant between-group difference. The authors concluded the findings do not support use of PRP for knee OA.
Bennell KL, Paterson KL, Metcalf BR, et al. — Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial. JAMA, 2021. DOI: 10.1001/jama.2021.19415.
-
A meta-analysis of 18 Level I randomized trials (811 patients receiving PRP, 797 receiving hyaluronic acid, mean follow-up 11.1 months) found mean improvement in total WOMAC scores was significantly higher with PRP (44.7%) than with hyaluronic acid (12.6%) (P<.01), and 6 of 11 VAS-reporting studies found significantly less pain with PRP at latest follow-up.
Belk JW, Kraeutler MJ, Houck DA, et al. — Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. American Journal of Sports Medicine, 2021. DOI: 10.1177/0363546520909397.
Would a clinic conversation help?
You're welcome to bring medicine names, old knee records, and the activity you most want back. The clinic can explain the exam, available care, and full cost before you decide.
There's time for questions. One number reaches the clinic team: (602) 837-PAIN.
Book a free consultation